10.1 General Guidelines and Requirements

  • Prior to any diagnostic or therapeutic administration verify the identity of the patient by more than one method.
  • Prior to a brachytherapy administration verify that, the patient’s name, radionuclide, activity, treatment site, and source removal time (if applicable) agree with the treatment plan and the written order of the authorized user physician.
  • Prior to an HDR administration verify that, the patient’s name, treatment site, and treatment plan agree with the written order of the authorized user physician.
  • Prior to the administration of an external beam therapy dose verify that, the patient’s name, treatment mode, dose fractionation, and site of treatment agree with the treatment plan and the written order of the authorized user physician.
  • Prior to the administration of radiopharmaceuticals verify that, the patient’s name, radionuclide, chemical form, activity, and administration site agree with the authorized user physician’s written order.
  • Maintain written quality control procedures and records for all equipment used to measure radioactivity and obtain images from radionuclide studies.
  • Maintain written quality control procedures and records of HDR, external beam therapy machines, and treatment planning equipment as required by regulation.
  • Maintain an accurate inventory record of radiopharmaceuticals, sealed sources and radioactive waste.
  • Perform and document radiation contamination and ambient surveys of areas where PET radiopharmaceuticals are stored and administered as required by regulation. 
  • Pregnant staff should not assist with brachytherapy patient care or source manipulation.
  • Wear appropriate protective apparel and use protective equipment and remote handling tools as necessary for the type and quantity of ionizing radiation present.
  • Wear assigned personal dosimeters while working in areas where radioactive materials are used and stored.
  • Do not eat, drink, apply cosmetics, or store personal effects in areas where radioactive materials are used or stored.
  • Remove or obliterate all radiation warning labels on items that no longer contain radioactive material or produce ionizing radiation as determined by the appropriate survey.
  • Notify EHS of any suspected diagnostic or therapeutic administration error.
  • Notify EHS of any radioactive material spills, and/or incidents involving potential personnel contamination, or exposure.